PTC Therapeutics, Inc. (PTCT)
72.74
-0.73
(-0.99%)
USD |
NASDAQ |
Aug 26, 16:00
72.74
0.00 (0.00%)
After-Hours: 17:12
PTC Therapeutics Total Return Level : 73.47 for Aug. 25, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 25, 2026 | 73.47 |
| August 24, 2026 | 71.06 |
| August 21, 2026 | 69.82 |
| August 20, 2026 | 70.52 |
| August 19, 2026 | 73.67 |
| August 18, 2026 | 72.63 |
| August 17, 2026 | 72.88 |
| August 14, 2026 | 71.70 |
| August 13, 2026 | 71.97 |
| August 12, 2026 | 72.64 |
| August 11, 2026 | 73.70 |
| August 10, 2026 | 74.63 |
| August 07, 2026 | 73.31 |
| August 06, 2026 | 70.85 |
| August 05, 2026 | 69.21 |
| August 04, 2026 | 69.10 |
| August 03, 2026 | 68.12 |
| July 31, 2026 | 68.01 |
| July 30, 2026 | 75.52 |
| July 29, 2026 | 74.49 |
| July 28, 2026 | 75.39 |
| July 27, 2026 | 75.80 |
| July 24, 2026 | 76.82 |
| July 23, 2026 | 78.45 |
| July 22, 2026 | 78.40 |
| Date | Value |
|---|---|
| July 21, 2026 | 78.50 |
| July 20, 2026 | 78.01 |
| July 17, 2026 | 78.59 |
| July 16, 2026 | 78.52 |
| July 15, 2026 | 78.84 |
| July 14, 2026 | 78.06 |
| July 13, 2026 | 81.33 |
| July 10, 2026 | 84.85 |
| July 09, 2026 | 89.55 |
| July 08, 2026 | 88.57 |
| July 07, 2026 | 89.20 |
| July 06, 2026 | 85.44 |
| July 02, 2026 | 83.31 |
| July 01, 2026 | 81.35 |
| June 30, 2026 | 81.57 |
| June 29, 2026 | 81.57 |
| June 26, 2026 | 84.43 |
| June 25, 2026 | 84.51 |
| June 24, 2026 | 84.41 |
| June 23, 2026 | 82.13 |
| June 22, 2026 | 80.96 |
| June 18, 2026 | 78.98 |
| June 17, 2026 | 78.53 |
| June 16, 2026 | 73.27 |
| June 15, 2026 | 76.77 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Insmed, Inc. | 123.89 |
| Madrigal Pharmaceuticals, Inc. | 512.16 |
| Protagonist Therapeutics, Inc. | 150.59 |
| Biogen, Inc. | 220.77 |
| BioMarin Pharmaceutical, Inc. | 66.12 |